Skip to main content
. 2016 Oct 25;8(11):18424–18434. doi: 10.18632/oncotarget.12906

Table 3A. Sensitivities and specificities of total testosterone for each of the outcomes.

Testosterone (ng/dL) Sensitivity (95% C.I.) Specificity (95% C.I.)
Upstaging 344 0.70 (0.59 to 0.8) 0.90 (0.86 to 0.93)
Upgrading 431 0.60 (0.52 to 0.67) 0.70 (0.63 to 0.77)
Unfavorable disease 302 0.85 (0.81 to 0.89) 0.82 (0.64 to 0.95)
Predominant Gleason 4 315 0.53 (0.4 to 0.66) 0.87 (0.83 to 0.91)